Skip to main content

Carlos González Cruz

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Carlos González Cruz

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Melanoma
Vall Hebron Institut de Recerca

Projects

Recerca biomèdica and melanomes mod anim i càncer

IP: Juan Angel Recio Conde
Collaborators: Paula Granado Martinez, Kimberley Anne McGrail Fernández, Carlos González Cruz, Vicente García-Patos Briones, Eva Muñoz Couselo
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 60000
Reference: 2021 SGR 00653
Duration: 01/01/2022 - 30/06/2025

Related news

The findings pave the way for the development of new therapeutic strategies combining immunotherapy with p38α protein inhibitors.

The ten groups within the Cancer Area combine basic, translational and clinical research to identify new targets, biomarkers and therapeutic strategies

The study reveals that if the exposure of newborns to solar radiation of sufficient intensity to provoke a skin reaction is simultaneous with the activation of the BRAFv600E gene, it can trigger an uncontrolled proliferation of cancer cells.

Related professionals

Ana Maria Barrios Franquesa

Ana Maria Barrios Franquesa

Research technician
Research on Aging, Frailty and Transitions in Barcelona
Read more
Miquel Perea Garcia

Miquel Perea Garcia

Main researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more
Laia Boixet Lladó

Laia Boixet Lladó

Research technician
Biomedical Research in Gynaecology
Read more
Laia Clemente Casals

Laia Clemente Casals

Gestió i Administració
Technological Infrastructure Unit
Digital Transformation Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.